drugset / Trial / NCT02209519

Randomized Controlled Trial of Treatment of Male Partners of Women With BV

NCT02209519 ↗

RandomizedSingle-groupQuadruple-blindPrevention

Summary

Male partners of womoen with recurrent bacteria vaginosis are randomized to treatment with metronidazole or placebo to compare the rates of recurrent BV in the women

Timeline

Start
2015-02
Primary completion
2019-03
Completion
2019-03

Outcome

Missed primary endpoint

paper there was no significant difference between treatment arms for the primary outcome. PMID 33383580 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Metronidazole Small molecule 500 mg Oral

Indications